Tag | Content |
---|
EnhancerAtlas ID | HS061-05097 |
Organism | Homo sapiens |
Tissue/cell | GM12892 |
Coordinate | chr12:4273730-4274770 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
NKX2-3 | MA0672.1 | chr12:4274721-4274731 | TTCAAGTGGT | - | 6.02 | ZNF263 | MA0528.1 | chr12:4274548-4274569 | TTCTTCCCCATTTCCTCCTCA | - | 6.13 | ZNF263 | MA0528.1 | chr12:4274135-4274156 | GGAGGAGCCGGGAGGGAGAGG | + | 6.1 | ZNF263 | MA0528.1 | chr12:4273779-4273800 | GCCTTCTCCTGCTCCTCCTCT | - | 6.45 |
|
| Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
SE_10702 | chr12:4273459-4274966 | CD19_Primary | SE_11778 | chr12:4273012-4275197 | CD20 | SE_58886 | chr12:4216067-4279606 | Ly3 | SE_61003 | chr12:4215547-4279853 | HBL1 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH12I004164 | chr12 | 4273272 | 4275018 |
|
Enhancer Sequence | GGAATGGGCC TGGAGCCGTG AGCCGTCCCC TTCGCTAACC CCCAACCCCG CCTTCTCCTG 60 CTCCTCCTCT CTTCACTCTT CCTGCCTCTC GGCTCCGGGG TCTCCTCGCT TCCCCGCAGT 120 CCCCGCCCCC CAGTTCCCAA AGCGGCACCC GGGCCTCGCC TCCTTCCAGC GGAGCCGCGC 180 GCCCTGCGTC CTGGCCTCCC CGCCCCGAGT CCCCTTCCCT GGAGCCTGGG GGACCGACAG 240 TCGCGGGCCA CGCACGCGGT CCCAGCCTCG CCGTCCGCCC CGGGGAGAGC TGGAAGGTGG 300 GCCCGGATCT CCCACATCAC TATGAGCTCA TTCCAGCCCC GGCCAAGCAA AGCCTGGCCC 360 TACTCGCTCC ACATGCATTT CAGTCTCCTC TCGCCTTTCA TGCGCGGAGG AGCCGGGAGG 420 GAGAGGATGT GACCTCATCT GCGCGGCATC TGAGCCCAGG GGTGCCCCAG CTCTTCCACC 480 CAGGCCGCTC CCCGAGCCCA GCTCCCCGCG CCCCTCTCTC TATCCAGGAG AGACGCATTG 540 GACAGCCAGG AGGGCTCGAC GTGGAAGGAA AGGAAGCTGC AATTCTGGGA CAGGGGCAGA 600 CGGGAGAGGA AGTGAACGTG GCTAAACGCT CACTTTATGT AAAACGTCCC CCAGACTAGA 660 ATCTCGTCCA CAGAGCTGCA CACATACACT CGCACGGGCC CGGCTTGTAC TCAGGCAGGC 720 ACACTCGCCC CCCGCCGTCC CCACCGCATC CCCCATACCC GTCCTAACTC ACTCCAGCCC 780 CAATACAACC AAAAGGCATG AATTCAGGCG AAGGCGTTTT CTTCCCCATT TCCTCCTCAT 840 GGCAGCAACG GAAACCTGAA TCTCAGAGCT GCCATGGGAC CAGGGGGCCA ACAGACCAGA 900 GGCACCATCC TCAGAGCCCC CGGTCTGCCT GGGACTGGGA GCATGGCTGT GGCGCCCAAT 960 GAGAACATAG TGTCCATAGT GACCATGATT CTTCAAGTGG TGTCTGAATT TCCCACATTA 1020 GCTAAATTCC TTTGGGAGCT 1040
|